SEC Form 4 · accession 0001093557-19-000084
DEXCOM INC · DXCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven Robert Pacelli
Officer — EVP Strategy and Corporate Dev
Period of report
Mar 12, 2019
Accepted (ET)
Mar 13, 2019 · 7:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001093557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Mar 12, 2019 | S | 2,190 | $142.7922 | D | 112,534 | D | |
| Common StockF1,F2 | Mar 12, 2019 | S | 6,399 | $142.7922 | D | 106,135 | D | |
| Common StockF1,F2 | Mar 12, 2019 | S | 2,222 | $142.7922 | D | 103,913 | D | |
| Common StockF3,F2 | Mar 12, 2019 | G | 350 | $0.00 | D | 103,563 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- F2Included in this number are 49,825 unvested restricted stock units, 14,987 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 25,668 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 9,170 of which were granted on March 8, 2017 and shall vest through March 8, 2020.
- F3This transaction represents a gift of securities made by the reporting person. This is not a market transaction, thus no price has been reported. Transferor retains no beneficial or voting interest in the transferred shares.